Thrivent Financial for Lutherans’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.78M | Sell |
9,715
-4,272
| -31% | -$787K | ﹤0.01% | 1537 |
|
|
2025
Q4 | $2.46M | Sell |
13,987
-68,104
| -83% | -$11.1M | ﹤0.01% | 1340 |
|
|
2025
Q3 | $11.5M | Buy |
82,091
+63,896
| +351% | +$8.64M | 0.02% | 574 |
|
|
2025
Q2 | $2.29M | Buy |
18,195
+3,544
| +24% | +$442K | 0.01% | 1262 |
|
|
2025
Q1 | $2M | Sell |
14,651
-1,185
| -7% | -$169K | ﹤0.01% | 1286 |
|
|
2024
Q4 | $2.42M | Sell |
15,836
-172,817
| -92% | -$29.1M | ﹤0.01% | 1296 |
|
|
2024
Q3 | $36.6M | Sell |
188,653
-3,854
| -2% | -$806K | 0.07% | 327 |
|
|
2024
Q2 | $44.6M | Sell |
192,507
-8,889
| -4% | -$1.93M | 0.09% | 277 |
|
|
2024
Q1 | $43.4M | Sell |
201,396
-57,961
| -22% | -$13.6M | 0.09% | 282 |
|
|
2023
Q4 | $67.1M | Sell |
259,357
-21,290
| -8% | -$5.23M | 0.15% | 204 |
|
|
2023
Q3 | $72.1M | Sell |
280,647
-8,657
| -3% | -$2.32M | 0.17% | 161 |
|
|
2023
Q2 | $82.4M | Sell |
289,304
-7,838
| -3% | -$2.33M | 0.19% | 155 |
|
|
2023
Q1 | $82.6M | Sell |
297,142
-1,466
| -0.5% | -$406K | 0.2% | 145 |
|
|
2022
Q4 | $82.7M | Sell |
298,608
-10,214
| -3% | -$2.88M | 0.21% | 127 |
|
|
2022
Q3 | $82.5M | Buy |
308,822
+47,482
| +18% | +$10.1M | 0.23% | 112 |
|
|
2022
Q2 | $53.3M | Sell |
261,340
-8,904
| -3% | -$1.82M | 0.14% | 192 |
|
|
2022
Q1 | $56.9M | Buy |
270,244
+10,967
| +4% | +$2.38M | 0.11% | 226 |
|
|
2021
Q4 | $62.2M | Buy |
259,277
+31,661
| +14% | +$8.14M | 0.12% | 217 |
|
|
2021
Q3 | $64.4M | Buy |
227,616
+37,331
| +20% | +$12.2M | 0.13% | 195 |
|
|
2021
Q2 | $65.9M | Buy |
190,285
+29,693
| +18% | +$9M | 0.13% | 195 |
|
|
2021
Q1 | $44.9M | Buy |
160,592
+7,208
| +5% | +$1.94M | 0.1% | 252 |
|
|
2020
Q4 | $37.6M | Sell |
153,384
-6,441
| -4% | -$1.66M | 0.09% | 291 |
|
|
2020
Q3 | $45.3M | Sell |
159,825
-6,971
| -4% | -$1.94M | 0.12% | 205 |
|
|
2020
Q2 | $44.6M | Sell |
166,796
-3,871
| -2% | -$1.16M | 0.13% | 192 |
|
|
2020
Q1 | $54M | Buy |
170,667
+79,761
| +88% | +$24.2M | 0.19% | 127 |
|
|
2019
Q4 | $27M | Buy |
90,906
+11,337
| +14% | +$3.15M | 0.08% | 298 |
|
|
2019
Q3 | $18.5M | Sell |
79,569
-34,912
| -30% | -$8.13M | 0.06% | 346 |
|
|
2019
Q2 | $26.8M | Sell |
114,481
-156,478
| -58% | -$36.1M | 0.08% | 278 |
|
|
2019
Q1 | $64M | Sell |
270,959
-174,100
| -39% | -$54.8M | 0.2% | 133 |
|
|
2018
Q4 | $134M | Buy |
445,059
+13,623
| +3% | +$4.35M | 0.48% | 41 |
|
|
2018
Q3 | $152M | Sell |
431,436
-3,571
| -0.8% | -$1.23M | 0.48% | 39 |
|
|
2018
Q2 | $126M | Buy |
435,007
+143,962
| +49% | +$40.5M | 0.41% | 49 |
|
|
2018
Q1 | $79.7M | Sell |
291,045
-18,425
| -6% | -$5.72M | 0.27% | 86 |
|
|
2017
Q4 | $98.6M | Sell |
309,470
-826
| -0.3% | -$265K | 0.33% | 66 |
|
|
2017
Q3 | $97.2M | Buy |
310,296
+69,173
| +29% | +$20.5M | 0.34% | 66 |
|
|
2017
Q2 | $65.4M | Sell |
241,123
-2,097
| -0.9% | -$554K | 0.27% | 94 |
|
|
2017
Q1 | $66.5M | Buy |
243,220
+191,910
| +374% | +$54.3M | 0.29% | 84 |
|
|
2016
Q4 | $14.6M | Buy |
51,310
+22,770
| +80% | +$6.75M | 0.06% | 294 |
|
|
2016
Q3 | $8.93M | Buy |
28,540
+21,769
| +322% | +$6.45M | 0.04% | 418 |
|
|
2016
Q2 | $1.64M | Buy |
6,771
+401
| +6% | +$106K | 0.01% | 937 |
|
|
2016
Q1 | $1.66M | Buy |
6,370
+100
| +2% | +$26.4K | 0.01% | 925 |
|
|
2015
Q4 | $1.92M | Sell |
6,270
-130
| -2% | -$37.4K | 0.01% | 864 |
|
|
2015
Q3 | $1.87M | Buy |
6,400
+300
| +5% | +$99.1K | 0.01% | 809 |
|
|
2015
Q2 | $2.46M | Sell |
6,100
-2,100
| -26% | -$843K | 0.01% | 623 |
|
|
2015
Q1 | $3.46M | Sell |
8,200
-20,350
| -71% | -$8.02M | 0.02% | 566 |
|
|
2014
Q4 | $9.69M | Sell |
28,550
-1,400
| -5% | -$453K | 0.05% | 330 |
|
|
2014
Q3 | $9.91M | Sell |
29,950
-8,150
| -21% | -$2.69M | 0.06% | 312 |
|
|
2014
Q2 | $12M | Buy |
38,100
+32,600
| +593% | +$9.81M | 0.07% | 294 |
|
|
2014
Q1 | $1.68M | Hold |
5,500
| – | – | 0.01% | 628 |
|
|
2013
Q4 | $1.54M | Sell |
5,500
-31,300
| -85% | -$8.1M | 0.01% | 664 |
|
|
2013
Q3 | $8.86M | Sell |
36,800
-930
| -2% | -$208K | 0.06% | 329 |
|
|
2013
Q2 | $8.12K | Buy |
+37,730
| New | +$8.06M | 0.05% | 349 |
|
Other funds holding BIIB
VCM
VPM
Thrivent Financial for Lutherans's BIIB Position: Q1 2026 in Review
Thrivent Financial for Lutherans reduced its Biogen (BIIB) stake by 31% in Q1 2026, selling an estimated $787K and leaving 9,715 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1537.
Thrivent Financial for Lutherans first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $152M in Q3 2018. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Thrivent Financial for Lutherans held 9,715 shares of Biogen worth $1.78M as of Q1 2026.
- Thrivent Financial for Lutherans sold 4,272 Biogen shares in Q1 2026, an estimated $787K.
- Biogen made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1537 holding.
- Thrivent Financial for Lutherans first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Thrivent Financial for Lutherans's Biogen position peaked at $152M in Q3 2018.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.